Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
vaccine mod mæslinger, fåresyge og rubella |
Is a |
False |
rubellavaccine |
Inferred relationship |
Some |
|
levende rubellavaccine pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
rubellavaccine |
Inferred relationship |
Some |
1 |
levende rubellavirusvaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
rubellavaccine |
Inferred relationship |
Some |
|
levende rubellavirusvaccine 0,5 ml/hætteglas pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
rubellavaccine |
Inferred relationship |
Some |
|
levende rubellavirusvaccine 0,5 ml/hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
rubellavaccine |
Inferred relationship |
Some |
|
rubellavaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
rubellavaccine |
Inferred relationship |
Some |
1 |
vaccine mod rubella og fåresyge |
Is a |
False |
rubellavaccine |
Inferred relationship |
Some |
|
rubellaimmunglobulin 25.000 IE pulver til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
rubellavaccine |
Inferred relationship |
Some |
|
Adverse reaction to rubella vaccine |
Causative agent |
False |
rubellavaccine |
Inferred relationship |
Some |
1 |
Allergy to rubella vaccine |
Causative agent |
False |
rubellavaccine |
Inferred relationship |
Some |
|
Administration of measles and mumps and rubella vaccine |
Direct substance |
False |
rubellavaccine |
Inferred relationship |
Some |
1 |
Administration of rubella vaccine |
Direct substance |
False |
rubellavaccine |
Inferred relationship |
Some |
1 |
Administration of booster dose of measles and mumps and rubella vaccine |
Direct substance |
False |
rubellavaccine |
Inferred relationship |
Some |
1 |
Administration of pre-school booster dose of vaccine product containing only Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (procedure) |
Direct substance |
False |
rubellavaccine |
Inferred relationship |
Some |
1 |
Administration of second dose of measles and mumps and rubella vaccine |
Direct substance |
False |
rubellavaccine |
Inferred relationship |
Some |
1 |
mæslinge- + fåresyge- + rubella- + varicellavaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
rubellavaccine |
Inferred relationship |
Some |
3 |
mæslinge-/fåresyge-/rubella-/varicellavaccine pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
rubellavaccine |
Inferred relationship |
Some |
3 |
Administration of second dose of measles and mumps and rubella vaccine |
Direct substance |
False |
rubellavaccine |
Inferred relationship |
Some |
1 |
Administration of pre-school booster dose of vaccine product containing only Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (procedure) |
Direct substance |
False |
rubellavaccine |
Inferred relationship |
Some |
1 |
Administration of measles and mumps and rubella and varicella virus vaccine |
Direct substance |
False |
rubellavaccine |
Inferred relationship |
Some |
1 |
Administration of second dose of vaccine product containing only Human alphaherpesvirus 3 and Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (procedure) |
Direct substance |
False |
rubellavaccine |
Inferred relationship |
Some |
1 |
Administration of rubella vaccine |
Direct substance |
False |
rubellavaccine |
Inferred relationship |
Some |
1 |
Administration of measles and mumps and rubella vaccine |
Direct substance |
False |
rubellavaccine |
Inferred relationship |
Some |
1 |
Administration of booster dose of measles and mumps and rubella vaccine |
Direct substance |
False |
rubellavaccine |
Inferred relationship |
Some |
1 |
Administration of rubella vaccine |
Direct substance |
False |
rubellavaccine |
Inferred relationship |
Some |
1 |
mæslinge-/fåresyge-/rubellavaccine pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
rubellavaccine |
Inferred relationship |
Some |
3 |
mæslinge-, fåresyge- og rubellavaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
rubellavaccine |
Inferred relationship |
Some |
3 |
Live measles + rubella vaccine injection dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
rubellavaccine |
Inferred relationship |
Some |
2 |
Allergy to rubella vaccine |
Causative agent |
False |
rubellavaccine |
Inferred relationship |
Some |
1 |
Administration of vaccine product containing only live attenuated Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (procedure) |
Direct substance |
False |
rubellavaccine |
Inferred relationship |
Some |
3 |
Administration of vaccine product containing only live attenuated Measles morbillivirus and Mumps orthorubulavirus and Rubella virus and Human alphaherpesvirus 3 antigens (procedure) |
Direct substance |
False |
rubellavaccine |
Inferred relationship |
Some |
3 |
Administration of measles and rubella vaccine |
Direct substance |
False |
rubellavaccine |
Inferred relationship |
Some |
2 |